Liquid-based cytology testing is the best method for early detection of cervical cancer

Cervical cancer is one of the most common malignant tumors of the female reproductive system, and its incidence rate ranks second only to breast cancer among female malignant tumors. In recent years, the incidence rate among young women has shown a clear upward trend. Only by preventing, screening and early diagnosing cervical cancer in women of childbearing age and raising public awareness of cervical cancer and early screening can we effectively reduce the incidence and mortality of cervical cancer in Chinese women.

Why is liquid-based cytology testing the best early detection method for cervical cancer?

Compared with the traditional Pap smear test, the currently recommended cervical cancer screening method is liquid-based cell testing, which is the best early detection method for cervical cancer determined by the World Health Organization. The reasons are:

1. Liquid-based cytology testing can overcome the inherent limitations of traditional smears, effectively solve the problem of inaccurate diagnosis caused by cell loss, poor smear quality, etc., and avoid missed diagnosis and misdiagnosis of precancerous lesions.

2. Liquid-based cell testing has a 64.4% higher detection rate for cervical precancerous lesions than traditional technologies. For example, the cell enrichment procedure of LCT liquid-based testing technology can effectively remove impurities and cell fragments that cover cells, making related cells easier to observe and diagnose, and more accurately diagnose early cervical cancer lesions, helping to reduce the mortality rate of cervical cancer among Chinese women.